New Thoughts on Immunoglobulin G4-Related Sclerosing Cholangitis.

Abstract:

:Immunoglobulin G4 (IgG4)-related sclerosing cholangitis (IgG4-SC) is the biliary manifestation of the multisystem IgG4-related disease. IgG4-SC presents with biliary strictures and/or masses that can bear a striking similarity to other malignant and inflammatory diseases. Diagnosis is based on a combination of clinical, biochemical, radiological, and histologic findings with careful exclusion of malignant disease. Corticosteroids are the mainstay of treatment with good clinical, biochemical, and radiological responses. This review provides a comprehensive overview of the current knowledge of the prevalence, clinical features, radiology and histology findings, diagnosis, treatment, natural history, and pathophysiology of IgG4-SC.

journal_name

Clin Liver Dis

journal_title

Clinics in liver disease

authors

Smit WL,Culver EL,Chapman RW

doi

10.1016/j.cld.2015.08.004

subject

Has Abstract

pub_date

2016-02-01 00:00:00

pages

47-65

issue

1

eissn

1089-3261

issn

1557-8224

pii

S1089-3261(15)00076-8

journal_volume

20

pub_type

杂志文章,评审
  • HBV/HCV Coinfection in the Era of HCV-DAAs.

    abstract::Epidemiologic studies suggest that 10% to 15% of patients infected with hepatitis C virus (HCV) are coinfected with hepatitis B virus (HBV) in the United States as a result of the shared modality of transmission, but the true prevalence is not known. The progression of liver disease to cirrhosis and hepatocellular car...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2019.04.003

    authors: Abdelaal R,Yanny B,El Kabany M

    更新日期:2019-08-01 00:00:00

  • Hepatobiliary manifestations of critically ill and postoperative patients.

    abstract::Liver dysfunction is common in both the critically ill and postoperative patient. Metabolic derangements secondary to sepsis, poor hepatic perfusion, total parenteral nutrition, in addition to hemodynamic and anesthetic-induced changes that occur during surgery, can cause liver damage ranging from small self-limited a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2010.09.004

    authors: Aronsohn A,Jensen D

    更新日期:2011-02-01 00:00:00

  • Viral Hepatitis Other than A, B, and C: Evaluation and Management.

    abstract::Viral hepatitis can cause a wide spectrum of clinical presentations from a benign form with minimal or no symptoms to acute liver failure or death. Hepatitis D coinfection and superinfection have distinct clinical courses, with the latter more likely leading to chronic infection. Management of chronic hepatitis D viru...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2020.04.008

    authors: Cheung A,Kwo P

    更新日期:2020-08-01 00:00:00

  • The Liver in Sickle Cell Disease.

    abstract::Patients with sickle cell disease can develop liver disease as a result of intrahepatic sickling of erythrocytes, viral hepatitis and iron overload secondary to multiple blood transfusions, and gallstone disease as a result of chronic hemolysis. The spectrum of clinical liver disease is wide and often multifactorial. ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.12.002

    authors: Theocharidou E,Suddle AR

    更新日期:2019-05-01 00:00:00

  • Issues unique to pediatric liver transplantation.

    abstract::Liver transplantation in pediatrics has become an accepted modality of treatment in end-stage liver disease and irreversible acute liver failure. Biliary atresia is the most common indication requiring liver transplantation in children. The diagnosis and causes of acute liver failure in children differ from those in a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2007.04.001

    authors: Kerkar N,Emre S

    更新日期:2007-05-01 00:00:00

  • Acute liver failure: a review.

    abstract::Since publication of the first descriptions of acute liver failure (ALF) as a distinct clinical entity in the 1950's, the understanding of the pathophysiologic mechanisms involved and the management options have increased substantially. ALF still represents a major challenge for todays hepatologists, because it can ra...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2006.05.010

    authors: Khan SA,Shah N,Williams R,Jalan R

    更新日期:2006-05-01 00:00:00

  • The role of the transjugular intrahepatic portal-systemic shunt in the management of variceal bleeding.

    abstract::For patients who present with variceal bleeding refractory to endoscopic and pharmacologic methods, TIPS is a new and effective therapy. Stents are used in selected patients with decompensated liver disease and those who anticipate liver transplantation within 6 to 12 months. Surveillance of TIPS with ultrasound, with...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70257-9

    authors: Faust TW,Sorrell MF

    更新日期:1997-05-01 00:00:00

  • Autoimmune hepatitis: diagnostic criteria, subclassifications, and clinical features.

    abstract::The diagnosis of AIH depends on the finding of several suggestive features together with careful exclusion of liver diseases of other etiologies. Wherever possible, the diagnosis should be confirmed histologically by an experienced hepatopathologist. Seronegativity for the conventional autoantibodies at presentation d...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(02)00019-3

    authors: McFarlane IG

    更新日期:2002-08-01 00:00:00

  • Relationships among stellate cell activation, progenitor cells, and hepatic regeneration.

    abstract::Hepatic stellate cells (HSC) play an important role in liver fibrogenesis. They are also key players in liver regeneration as part of the stem cell niche of hepatocytes and hepatic progenitor cells. They produce growth stimulating and inhibiting factors for these epithelial cell compartments. In addition, recent studi...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2008.07.014

    authors: Roskams T

    更新日期:2008-11-01 00:00:00

  • Primary biliary cirrhosis: the future.

    abstract::The answers to these questions are key to understanding the pathogenesis of PBC. Although the study of PBC is significantly retarded by the lack of an adequate animal model, the molecular technology to address these issues is advancing rapidly. In addition, the ability to isolate and culture human biliary epithelial c...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(03)00093-x

    authors: Mayo MJ

    更新日期:2003-11-01 00:00:00

  • Cardiovascular diseases and the liver.

    abstract::The dual blood supply of the liver, originating from the portal vein and the hepatic artery, makes it relatively resistant to minor circulatory disturbances. However, hepatic manifestations of common cardiovascular disorders are frequently encountered in both the inpatient and outpatient setting. Beginning with the ma...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2010.09.010

    authors: Weisberg IS,Jacobson IM

    更新日期:2011-02-01 00:00:00

  • Alcohol-induced liver disease.

    abstract::Hepatic changes resulting from the regular ingestion of alcohol are many and include fat infiltration, alcoholic hepatitis, and cirrhosis. Only 10% to 15% of chronic alcoholics develop liver disease. Women are more susceptible. An area of considerable importance is the high prevalence of concomitant infection with hep...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70099-4

    authors: Maddrey WC

    更新日期:2000-02-01 00:00:00

  • Appendix: The National Institutes of Health Consensus Development Conference Management of Hepatitis C 2002.

    abstract::The incidence of newly acquired hepatitis C infection has diminished in the United States. This decline is largely because of a decrease in cases among IDUs for reasons that are unclear and, to a lesser extent, to testing of blood donors for HCV. The virus is transmitted by blood, and such transmission now occurs prim...

    journal_title:Clinics in liver disease

    pub_type: 共识发展会议,杂志文章,评审

    doi:10.1016/s1089-3261(02)00078-8

    authors: Seeff LB,Hoofnagle JH

    更新日期:2003-02-01 00:00:00

  • Pharmacologic Management of Hepatic Encephalopathy.

    abstract::Pharmacologic management of hepatic encephalopathy includes a broad range of therapies. This article covers the specific mainstays of therapies, such as antimicrobials and laxatives, with an established evidence base. This article also covers newer modalities of therapies, such as fecal microbiota transplant, probioti...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2020.01.005

    authors: Mahpour NY,Pioppo-Phelan L,Reja M,Tawadros A,Rustgi VK

    更新日期:2020-05-01 00:00:00

  • Cirrhosis and Portal Hypertension in the Pediatric Population.

    abstract::Cirrhosis is a complex process in which the architecture of the liver is replaced by structurally abnormal nodules due to cirrhosis. Cirrhosis frequently leads to the development of portal hypertension. In children, portal hypertension may be caused by a wide range of etiologies, including extrahepatic portal vein obs...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.06.007

    authors: Chapin CA,Bass LM

    更新日期:2018-11-01 00:00:00

  • The Management of Hepatitis B in Liver Transplant Recipients.

    abstract::Liver transplant (LT) is now an established indication for patients with chronic hepatitis B, mainly because of the development and use of hepatitis B immunoglobulin (HBIG) and oral antivirals for prophylaxis. The combination of low-dose HBIG and antivirals has been considered the standard prophylaxis regimen to preve...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2016.06.004

    authors: Saab S,Chen PY,Saab CE,Tong MJ

    更新日期:2016-11-01 00:00:00

  • Serologic and molecular diagnosis of hepatitis B virus.

    abstract::Serologic assays for HBV are the mainstay diagnostic tools for HBV infection. However, the advent of molecular biology-based techniques has added a new dimension to the diagnosis and treatment of patients with chronic HBV infection. Over the past decade, improvements in molecular technology, permitting detection of as...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2004.02.001

    authors: Servoss JC,Friedman LS

    更新日期:2004-05-01 00:00:00

  • Management of Acute Hepatotoxicity Including Medical Agents and Liver Support Systems.

    abstract::Drug-induced liver injury (DILI) can be predictable or idiosyncratic and has an estimated incidence of approximately 20 cases per 100,000 persons per year. DILI is a common cause of acute liver failure in the United States. No accurate tests for diagnosing DILI exist, and its diagnosis is based on exclusion of other c...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2016.08.012

    authors: Gonzalez HC,Jafri SM,Gordon SC

    更新日期:2017-02-01 00:00:00

  • The Use of Liver Biopsy in Nonalcoholic Fatty Liver Disease: When to Biopsy and in Whom.

    abstract::Nonalcoholic fatty liver disease (NAFLD) is a common liver disorder that can be divided into benign steatosis or nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Elastography and scoring systems based on clinical features and routine biochemical testing can be used to assess fibrosis in patient...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2017.08.006

    authors: Gunn NT,Shiffman ML

    更新日期:2018-02-01 00:00:00

  • The use of decision analytic models to inform clinical decision making in the management of hepatocellular carcinoma.

    abstract::Decision analysis helps evaluate competing strategies under conditions of uncertainty in a wide variety of clinical settings. Despite some limitations, decision trees and Markov models remain essential tools for medical decision analysts. These techniques allow comparison of competing management strategies in a quanti...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2004.12.004

    authors: Kim WR

    更新日期:2005-05-01 00:00:00

  • New Methods of Testing and Brain Imaging in Hepatic Encephalopathy: A Review.

    abstract::The diagnosis of hepatic encephalopathy is predominantly clinical, and the tests available assist in the diagnosis only by excluding other causes. Covert hepatic encephalopathy, which is defined as abnormal performance on psychometric tests when standard neurologic examination is completely normal, has gained widespre...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2015.04.001

    authors: Edula RG,Pyrsopoulos NT

    更新日期:2015-08-01 00:00:00

  • Chronic Hepatitis C Virus Infection and Depression.

    abstract::Hepatitis C virus (HCV) infection is a systemic disease with hepatic and extrahepatic manifestations, including neuropsychiatric conditions. Depression is a frequent disorder, which has been reported in one-third of patients with HCV infection and has an estimated prevalence of 1.5 to 4.0 times higher than that observ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2017.03.007

    authors: Adinolfi LE,Nevola R,Rinaldi L,Romano C,Giordano M

    更新日期:2017-08-01 00:00:00

  • Expanded criteria donors.

    abstract::The greatest challenge facing liver transplantation today is the shortage of donor livers. Demand far exceeds supply, and this deficit has driven expansion of what is considered an acceptable organ. The evolving standard has not come without costs, however, as each new frontier of expanded donor quality (i.e., advanci...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2014.05.005

    authors: Feng S,Lai JC

    更新日期:2014-08-01 00:00:00

  • Natural history of primary biliary cirrhosis.

    abstract::Primary biliary cirrhosis is an insidious disease that progresses through the clinical phases: preclinical, asymptomatic, symptomatic, and liver insufficiency. The outlook of patients diagnosed with PBC has improved significantly over the past 2 decades because more patients are being diagnosed earlier in the disease ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2008.02.012

    authors: Mayo MJ

    更新日期:2008-05-01 00:00:00

  • Understanding and Treating Pruritus in Primary Biliary Cholangitis.

    abstract::Pruritus is a common symptom with primary biliary cholangitis. Research has focused on refining understanding of the neurohumoral pathways involved in transduction of pruritus from peripheral cutaneous receptors to the central nervous system, and identifying modulating drugs. Current treatments have variable efficacy ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2018.03.005

    authors: Carrion AF,Rosen JD,Levy C

    更新日期:2018-08-01 00:00:00

  • Optimizing treatment regimens in hepatitis C.

    abstract::Scientists and clinicians have made tremendous advances in understanding the pathogenesis of hepatitis C virus (HCV) infection and have developed impressive strategies for treating this hepatotropic virus in the short time since its discovery in 1989. This article goes beyond the current guidelines for the treatment o...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2006.08.024

    authors: Darling JM,Fried MW

    更新日期:2006-11-01 00:00:00

  • Mechanisms of ascites formation.

    abstract::Ascites is the most common complication of cirrhosis. It is associated with profound changes in the splanchnic and systemic circulation and with renal abnormalities. The development of ascites is related to the existence of severe sinusoidal portal hypertension that causes marked splanchnic arterial vasodilation and a...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70118-5

    authors: Cárdenas A,Bataller R,Arroyo V

    更新日期:2000-05-01 00:00:00

  • Hepatitis C and steatosis.

    abstract::Steatosis is a common finding in patients with chronic hepatitis C (CHC) due to a combination of the direct steatogenic effect of hepatitis C virus (HCV) and the prevalence of metabolic risk factors in the HCV population. Steatosis is now established as a risk factor for disease progression in CHC and significantly im...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/j.cld.2004.06.007

    authors: Dev A,Patel K,McHutchison JG

    更新日期:2004-11-01 00:00:00

  • Current status of pediatric liver transplantation.

    abstract::Increased survival for young liver transplant recipients has greatly improved. Increasing success has led to broader indications, thereby increasing the number of potential recipients. Pediatric liver centers are developing new strategies to cope with the ever-increasing demands for suitable size appropriate grafts. U...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70125-2

    authors: Abramson O,Rosenthal P

    更新日期:2000-08-01 00:00:00

  • Hepatic granulomas and hepatic sarcoidosis.

    abstract::The causes of hepatic granulomas are numerous and their identification can be difficult. Sarcoidosis is a main cause of hepatic granulomas. The mechanisms that initiate the formation of sarcoid granulomas are unknown. This article discusses the pathology of hepatic sarcoidosis and hepatic granulomas. ...

    journal_title:Clinics in liver disease

    pub_type: 杂志文章,评审

    doi:10.1016/s1089-3261(05)70108-2

    authors: Valla DC,Benhamou JP

    更新日期:2000-02-01 00:00:00